BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 19541038)

  • 1. Financing of global health: tracking development assistance for health from 1990 to 2007.
    Ravishankar N; Gubbins P; Cooley RJ; Leach-Kemon K; Michaud CM; Jamison DT; Murray CJ
    Lancet; 2009 Jun; 373(9681):2113-24. PubMed ID: 19541038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development assistance for health: past trends, associations, and the future of international financial flows for health.
    Dieleman JL; Schneider MT; Haakenstad A; Singh L; Sadat N; Birger M; Reynolds A; Templin T; Hamavid H; Chapin A; Murray CJ
    Lancet; 2016 Jun; 387(10037):2536-44. PubMed ID: 27086170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2019 Jun; 393(10187):2233-2260. PubMed ID: 31030984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public financing of health in developing countries: a cross-national systematic analysis.
    Lu C; Schneider MT; Gubbins P; Leach-Kemon K; Jamison D; Murray CJ
    Lancet; 2010 Apr; 375(9723):1375-87. PubMed ID: 20381856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sources and Focus of Health Development Assistance, 1990-2014.
    Dieleman JL; Graves C; Johnson E; Templin T; Birger M; Hamavid H; Freeman M; Leach-Kemon K; Singh L; Haakenstad A; Murray CJ
    JAMA; 2015 Jun; 313(23):2359-68. PubMed ID: 26080340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative financing instruments for global health 2002-15: a systematic analysis.
    Atun R; Silva S; Knaul FM
    Lancet Glob Health; 2017 Jul; 5(7):e720-e726. PubMed ID: 28619230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
    Global Burden of Disease 2020 Health Financing Collaborator Network
    Lancet; 2021 Oct; 398(10308):1317-1343. PubMed ID: 34562388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2020 5-11 Sep; 396(10252):693-724. PubMed ID: 32334655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995-2015.
    Global Burden of Disease Health Financing Collaborator Network
    Lancet; 2018 May; 391(10132):1799-1829. PubMed ID: 29678342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative financing for health: what is truly innovative?
    Atun R; Knaul FM; Akachi Y; Frenk J
    Lancet; 2012 Dec; 380(9858):2044-9. PubMed ID: 23102585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking total spending on tuberculosis by source and function in 135 low-income and middle-income countries, 2000-17: a financial modelling study.
    Su Y; Garcia Baena I; Harle AC; Crosby SW; Micah AE; Siroka A; Sahu M; Tsakalos G; Murray CJL; Floyd K; Dieleman JL
    Lancet Infect Dis; 2020 Aug; 20(8):929-942. PubMed ID: 32334658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public and private donor financing for health in developing countries.
    Howard LM
    Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Bill & Melinda Gates Foundation's grant-making programme for global health.
    McCoy D; Kembhavi G; Patel J; Luintel A
    Lancet; 2009 May; 373(9675):1645-53. PubMed ID: 19427959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development assistance for global tobacco control.
    Ross H; Stoklosa M
    Tob Control; 2012 Sep; 21(5):465-70. PubMed ID: 21680562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for additional government spending on HIV/AIDS in 137 low-income and middle-income countries: an economic modelling study.
    Haakenstad A; Moses MW; Tao T; Tsakalos G; Zlavog B; Kates J; Wexler A; Murray CJL; Dieleman JL
    Lancet HIV; 2019 Jun; 6(6):e382-e395. PubMed ID: 31036482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Countdown to 2015: assessment of official development assistance to maternal, newborn, and child health, 2003-08.
    Pitt C; Greco G; Powell-Jackson T; Mills A
    Lancet; 2010 Oct; 376(9751):1485-96. PubMed ID: 20850869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking development assistance for health to fragile states: 2005-2011.
    Graves CM; Haakenstad A; Dieleman JL
    Global Health; 2015 Mar; 11():12. PubMed ID: 25886046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global health development assistance remained steady in 2013 but did not align with recipients' disease burden.
    Dieleman JL; Graves CM; Templin T; Johnson E; Baral R; Leach-Kemon K; Haakenstad AM; Murray CJ
    Health Aff (Millwood); 2014 May; 33(5):878-86. PubMed ID: 24714869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Global Fund's resource allocation decisions for HIV programmes: addressing those in need.
    Avdeeva O; Lazarus JV; Aziz MA; Atun R
    J Int AIDS Soc; 2011 Oct; 14():51. PubMed ID: 22029667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor Financing of Global Mental Health, 1995-2015: An Assessment of Trends, Channels, and Alignment with the Disease Burden.
    Charlson FJ; Dieleman J; Singh L; Whiteford HA
    PLoS One; 2017; 12(1):e0169384. PubMed ID: 28046059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.